Latest Market Activity News

Ovanti’s US payments brand Flote has partnered with cloud-native platform Gr4vy to launch scalable, responsible buy now pay later solutions in the US market starting 2026.

Metal Bank Limited addresses ASX concerns over recent share price volatility, confirming a pending Mineral Resource Estimate announcement and recent strategic moves as key drivers.

Tissue Repair Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with listing rules.

Volt Resources Limited has had its trading suspension lifted following the release of an announcement about a new equity funding transaction, signaling renewed market activity.

Orthocell has achieved its first commercial sales of Remplir™ in Hong Kong, marking a pivotal step in its Asian growth strategy and expanding its footprint across key global markets.

OD6 Metals has responded to an ASX price query following a notable rise in its share price and trading volume, confirming no undisclosed information exists and attributing the market activity to an independent research report.

The Agency Group Australia has set a new record by surpassing $1 billion in residential property sales in November 2025, driven by strong market activity and agent productivity across multiple states.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

Cokal Limited has clarified the recent spike in its share price and trading volume, attributing the market activity to a series of operational milestones and strategic partnerships rather than undisclosed information.

Macquarie Group Limited has updated details for its interim dividend, confirming a fully franked payout of AUD 2.80 per share and setting the Dividend Reinvestment Plan price at AUD 195.34.

QPM Energy Limited has had its trading suspension lifted following the announcement of a strategic investment term sheet and a capital raising, signaling renewed momentum for the energy company.

Proteomics International Laboratories has clarified that no undisclosed information explains its recent share price jump, pointing instead to recent Medicare reimbursement decisions and key product developments.